Literature DB >> 21615754

Pharmacokinetics and bioavailability of cefquinome in rabbits following intravenous and intramuscular administration.

Y H Hwang1, I B Song, H K Lee, T W Kim, M S Kim, J H Lim, B K Park, H I Yun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21615754     DOI： 10.1111/j.1365-2885.2011.01289.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN： 0140-7783            Impact factor:   1.786


× No keyword cloud information.
  4 in total

1.  Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle.

Authors:  Ijaz Ahmad; Haihong Hao; Lingli Huang; Pascal Sanders; Xu Wang; Dongmei Chen; Yanfei Tao; Shuyu Xie; Kuang Xiuhua; Juan Li; Wan Dan; Zonghui Yuan
Journal:  Front Microbiol       Date:  2015-06-17       Impact factor: 5.640

2.  Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.

Authors:  Femke J Taverne; Ingeborg M van Geijlswijk; Dick J J Heederik; Jaap A Wagenaar; Johan W Mouton
Journal:  BMC Vet Res       Date:  2016-09-06       Impact factor: 2.741

3.  Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus).

Authors:  Dong-Hao Zhao; Xu-Feng Wang; Qiang Wang; Liu-Dong Li
Journal:  BMC Vet Res       Date:  2017-07-28       Impact factor: 2.741

4.  In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.

Authors:  Yang Yu; Yu-Feng Zhou; Mei-Ren Chen; Xiao Li; Gui-Lin Qiao; Jian Sun; Xiao-Ping Liao; Ya-Hong Liu
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.